Results 201 to 210 of about 49,283 (257)

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse models. [PDF]

open access: yesJHEP Rep
Zhang YW   +12 more
europepmc   +1 more source

Single-cell analysis of heterogeneity in reverted hiPSC-derived human hepatic stellate cells. [PDF]

open access: yesJHEP Rep
Wang X   +11 more
europepmc   +1 more source

Identification of novel gene expression programs in thrombin-stimulated hepatic stellate cells. [PDF]

open access: yesRes Pract Thromb Haemost
Mac NA   +5 more
europepmc   +1 more source

Rubimaillin ameliorates liver fibrosis by triggering the ferroptosis of activated hepatic stellate cells through targeting CPT1A. [PDF]

open access: yesInt J Biol Sci
Zhang D   +11 more
europepmc   +1 more source

Integrative Multiomics Analysis Identifies HK2 as a Key Regulator of Metabolic Reprogramming in Hepatic Stellate Cells. [PDF]

open access: yesHum Mutat
Han L   +11 more
europepmc   +1 more source

Proteomic analysis of 7-octenoic acid antifibrotic effects in TGF-β1 activated hepatic stellate cells. [PDF]

open access: yesSci Rep
Buakaew W   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy